Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model

A major goal for improving tuberculosis therapy is to identify drug regimens with improved efficacy and shorter treatment durations. Shorter therapies improve patient adherence to the antibiotic regimens, which, in turn, decreases resistance emergence. Mycobacterium tuberculosis exists in multiple m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Louie, Arnold, Duncanson, Brandon, Myrick, Jenny, Maynard, Michael, Nole, Jocelyn, Brown, David, Schmidt, Stephan, Neely, Michael, Scanga, C. A., Peloquin, Charles, Drusano, G. L.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2018
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256764/
https://ncbi.nlm.nih.gov/pubmed/30249693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01470-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars